We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Recommends Second PCSK9 Inhibitor for LDL Cholesterol
FDA Panel Recommends Second PCSK9 Inhibitor for LDL Cholesterol
For the second time in two days, the FDA has recommended approval of a PCSK9 inhibitor as an effective and relatively safe means of lowering bad LDL cholesterol.